FDA NDC Directory · JSON-LD · Markdown

Neostigmine Methylsulfate

NDC 76045-383 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA203629
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (1 mg/mL)
Marketing started20180918
Package count1

External sources

Source: openFDA. Public-domain (CC0).